L Wang - Covalent Associates | 人才画像

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 17 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 4514: Discovery of potent and orally bioavailable degraders of HPK1 based on a novel HPK1 binder

Zhimin Zhang, Mengqiang Wu, Ling Wang, Xi Yang, Zhiping Zhang, Liubin Guo, Hao Pan, Mengting Zhao,Linli Wang, Sirui Liu, Zhao Dong, Chunhua Jiang,

Cancer Researchno. 6_Supplement (2024): 4514-4514

Cited0Views0Bibtex

Abstract LB318: SB-4826, a first-in-class oral, covalent inhibitor of SUMO E1 that induces IFN signaling and inhibits tumor growth as monotherapy and in combination with immune checkpoint blockade

Jude Canon, Ashley Callinan,Sarah Bradley,Laurie Wang, Mackenzie Kui, Ariel Wein, Gabriele Sulli, Peter Buchowiecki,Fang‐Tsao Hong, Miles Kubota, Mary Walton,Victor J. Cee

Cancer Researchno. 8_Supplement (2023): LB318-LB318

Cited0Views0Bibtex

Supplementary Figure 1 from Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody

Angela Coxon,James Bready,Hosung Min,Stephen Kaufman,Juan Leal,Dongyin Yu,Tani Ann Lee,Ji-Rong Sun,Juan Estrada,Brad Bolon,James McCabe,Ling Wang,

crossref（2023）

Cited0Views0Bibtex

SB-4826, a first-in-class oral, covalent inhibitor of SUMO E1 that induces IFN signaling and inhibits tumor growth as monotherapy and in combination with immune checkpoint blockade

Jude R. Canon, Ashley Callinan,Sarah Bradley,Laurie Wang, Mackenzie Kui, Ariel Wein, Gabriele Sulli, Peter Buchowiecki,Fang-Tsao Hong, Miles Kubota, Mary Walton,Victor J. Cee

CANCER RESEARCHno. 8 (2023)

Cited0Views0Bibtex

Supplementary Methods, Figure Legends, and References from Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody

Angela Coxon,James Bready,Hosung Min,Stephen Kaufman,Juan Leal,Dongyin Yu,Tani Ann Lee,Ji-Rong Sun,Juan Estrada,Brad Bolon,James McCabe,Ling Wang,

crossref（2023）

Cited0Views0Bibtex

Amg 511, A Potent And Selective Class I Pi3k Inhibitor, Demonstrates Anti-Tumor Activity In Multiple Xenograft Models

Nan Zhang,Sean Caenepeel,Ling Wang,Mark H Norman,Richard Kendall,Terri Burgess,Robert Radinsky,Paul E Hughes,Daniel Freeman

CANCER RESEARCH（2012）

Cited1Views0Bibtex

In Vitro Characterization Of Amg 511, A Potent And Selective Class I Pi3k Inhibitor For The Treatment Of Cancer

Sean Caenepeel,Nan Zhang,Ling Wang,Mark H Norman,Terri Burgess,Robert Radinsky,Richard Kendall,Daniel Freeman,Paul E Hughes

CANCER RESEARCH（2012）

Cited0Views0Bibtex

Investigations Of Various Heterocycles To Improve Metabolic Stability Within A Series Of Pi3k/Mtor Dual Inhibitors

Markian M. Stec,Kristin L. Andrews,Shon K. Booker,Sean Caenepeel,Daniel J. Freeman,Jian Jiang,Lillian Liao,John Mccarter,Erin Mullady,Tisha San Miguel,Raju Subramanian,Nuria Tamayo,

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY（2011）

Cited0Views0Bibtex

text-Dependent Role of Angiopoietin-1 Inhibition in the pression of Angiogenesis and Tumor Growth: Implications

Angel Ji-Ron, David Eunju Donal,James Bready,Hosung Min,Stephen Kaufman,Juan Leal,Dongyin Yu,Tani Ann Lee,Juan Estrada,Brad Bolon,James McCabe,Ling Wang,

semanticscholar（2010）

Cited0Views0Bibtex

Discovery text-Dependent Role of Angiopoietin-1 Inhibition in the pression of Angiogenesis and Tumor Growth : Implications Ther AMG 386 , an Angiopoietin-1 / 2 – Neutralizing Peptibody

a Coxon,James Bready,Hosung Min,Stephen Kaufman,Juan Leal,Dongyin Yu,Tani Ann Lee, g Sun,Juan Estrada,Brad Bolon,James McCabe,Ling Wang,

semanticscholar（2010）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn